ストックスクリーナーアプリを入手
0.57
1.28%
-0.0074
アフターアワーズ：
.57
前日終値:
$0.5774
開ける：
$0.5628
24時間の取引高:
1.15M
Relative Volume:
0.22
時価総額：
$18.97M
収益：
$476.00K
当期純損益:
$-38.52M
株価収益率:
-0.6305
EPS:
-0.9041
ネットキャッシュフロー:
$-39.89M
1週間 パフォーマンス:
-0.68%
1か月 パフォーマンス:
-3.06%
6か月 パフォーマンス:
-60.96%
1年 パフォーマンス:
-79.27%
1日の値動き範囲:
$0.5627
$0.575
1週間の範囲:
$0.557
$0.5899
52週間の値動き範囲:
$0.2805
$2.94
Vyne Therapeutics Inc Stock (VYNE) Company Profile
名前
Vyne Therapeutics Inc
セクター
電話
800-775-7936
住所
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
VYNE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.57 | 19.22M | 476.00K | -38.52M | -39.89M | -0.9041 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-31 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-11-18 | 開始されました | BTIG Research | Buy |
| 2021-12-06 | 再開されました | H.C. Wainwright | Buy |
Vyne Therapeutics Inc (VYNE) 最新ニュース
Support Test: Can SunCar Technology Group Inc. scale operations efficientlyMarket Movers & Verified Swing Trading Watchlists - baoquankhu1.vn
Block Trades: Is VersaBank a potential multi baggerJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn
Is Sonoco Products Company exposed to currency risksMarket Growth Report & Verified Entry Point Signals - baoquankhu1.vn
Volume Summary: Is VYNE Therapeutics Inc stock showing strong momentumWeekly Risk Report & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Analysis Recap: What is the long term forecast for VYNE Therapeutics Inc stockQuarterly Growth Report & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Aug Opening: How does CCLDO correlate with NasdaqJuly 2025 Institutional & Technical Buy Zone Confirmations - baoquankhu1.vn
Weekly Earnings: Is SEALPRB stock a value trapJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Aug EndMonth: Why is VYNE Therapeutics Inc stock going upWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn
Is VYNE Therapeutics Inc. stock positioned well for digital economyJuly 2025 Pullbacks & Safe Entry Trade Reports - Улправда
Will VYNE Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Trends & AI Enhanced Trading Alerts - Улправда
US Stocks Recap: Will VYNE Therapeutics Inc stock remain a Wall Street favoriteJuly 2025 Gainers & Free Safe Capital Growth Stock Tips - Bộ Nội Vụ
What insider trading reveals about VYNE Therapeutics Inc. stockJuly 2025 Chart Watch & Reliable Breakout Forecasts - ulpravda.ru
VYNE Therapeutics Inc. (NASDAQ:VYNE) Short Interest Down 18.2% in December - Defense World
VYNE Therapeutics Inc. (VYNE) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
VYNE SEC FilingsVyne Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Vyne Therapeutics shares surge on merger deal with Yarrow Bioscience - MSN
Why VYNE Therapeutics Inc. stock remains resilient2025 EndofYear Setup & Entry Point Confirmation Signals - Улправда
VYNE Therapeutics to merge with Yarrow Bioscience, secures $200M financing; shares up - MSN
Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages FOLD, VYNE, HTBK, FMNB Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
How VYNE Therapeutics Inc. stock compares to industry benchmarksMarket Sentiment Review & AI Enhanced Market Trend Forecasts - Улправда
Should I hold or sell VYNE Therapeutics Inc. stock in 2025Market Activity Summary & High Conviction Trade Alerts - Улправда
Is VYNE Therapeutics Inc. stock resilient to inflation2025 Market Outlook & AI Based Buy and Sell Signals - Улправда
Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders - PR Newswire
Risk Analysis: Will VYNE Therapeutics Inc. stock benefit from automation2025 Buyback Activity & Real-Time Volume Surge Alerts - Улправда
3 Penny Stocks to Watch Now, 12/18/25 - TipRanks
VYNE Therapeutics to merge with Yarrow Bioscience in $200 million deal - Investing.com
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of VYNE Therapeutics Inc. (NASDAQ: VYNE) - PR Newswire
VYNE Therapeutics Inc. (VYNE) Stock: Soars 55.45% on Merger Announcement with Yarrow Bioscience - parameter.io
Roundup: Harbor BioMed Announces Collaboration and License Agreement with Bristol Myers, Squibb, VYNE Therapeutics Enters Merger Agreement with Yarrow Bioscience - PharmExec.com
VYNE Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of VYNE Therapeutics Inc. is Fair to Shareholders - The AI Journal
VYNE Therapeutics: A New Chapter in Autoimmune Disease with Yarrow Bioscience - FinancialContent
Transcript : VYNE Therapeutics Inc., Yarrow Bioscience, Inc.M&A Call - marketscreener.com
VYNE Therapeutics (VYNE) Surges on Merger with Yarrow Bioscience - GuruFocus
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Crude Oil Rises Over 1%; General Mills Earnings Top Views - Benzinga
Yarrow Bioscience, Inc. entered into an Agreement and Plan of Merger and Reorganization to acquire VYNE Therapeutics Inc. in a reverse merger transaction. - marketscreener.com
VYNE: VYNE and Yarrow merge to advance YB-101 for Graves' disease and TED, backed by $200M funding - TradingView — Track All Markets
Dow Jumps 150 Points; Jabil Posts Upbeat Earnings - Benzinga
Vyne Therapeutics stock soars after merger with Yarrow Bioscience By Investing.com - Investing.com Nigeria
Vyne Therapeutics stock soars after merger with Yarrow Bioscience - Investing.com
VYNE Announces Merger with Yarrow Bioscience, Focuses on TSHR An - GuruFocus
VYNE Therapeutics Announces Merger with Yarrow Bioscience - TipRanks
VYNE Therapeutics, Yarrow Bioscience enter merger agreement - TipRanks
Vyne Therapeutics and Yarrow Bioscience announce merger agreement - marketscreener.com
VYNE FinancialsIncome Statement - Quiver Quantitative
VYNE and Yarrow Bioscience to merge in all-stock transaction - Investing.com
VYNE Therapeutics (VYNE) plans merger with Yarrow, Yarrow to own 97% - Stock Titan
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement - marketscreener.com
VYNE Therapeutics Inc Stock Analysis and ForecastPrice Action Trading & Backtest Your Strategy Before You Risk Money - earlytimes.in
[Form 4] VYNE Therapeutics Inc. Insider Trading Activity - Stock Titan
Vyne Therapeutics Inc (VYNE) 財務データ
収益
当期純利益
現金流量
EPS
2.09%
0.48%
大文字化:
|
ボリューム (24 時間):